Next-Generation Sequencing: Targeting Targeted Therapies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25847989.
- Also identified by DOI 10.1158/1078-0432.CCR-15-0407.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Next-generation sequencing (NGS) has given new perspective in oncology. With the ongoing development of targeted therapies, NGS is evolving molecular diagnostics by providing comprehensive interrogation of clinically actionable genomic aberrations in tumors. Having this assay as the primary testing method produces clinically beneficial results. See related article by Drilon et al., p. 3631.
Medical subject headings
- Adenocarcinoma
- Gene Rearrangement
- Genome, Human
- High-Throughput Nucleotide Sequencing
- Lung Neoplasms